Outcomes in Multivessel Coronary Disease Stratified by The Society of Thoracic Surgeons Risk
Autor: | Oscar C. Marroquin, Floyd Thoma, Forozan Navid, Catalin Toma, Conrad Smith, Jianhui Zhu, Arman Kilic, Saloni Kapoor, Suresh Mulukutla, Joon S. Lee, Ibrahim Sultan |
---|---|
Rok vydání: | 2020 |
Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Acute coronary syndrome medicine.medical_treatment Population Coronary Artery Disease Revascularization Percutaneous Coronary Intervention Internal medicine medicine Humans cardiovascular diseases Coronary Artery Bypass education Retrospective Studies Surgeons education.field_of_study Framingham Risk Score business.industry Percutaneous coronary intervention medicine.disease surgical procedures operative Treatment Outcome Drug-eluting stent Conventional PCI Cohort Surgery Cardiology and Cardiovascular Medicine business |
Zdroj: | The Annals of thoracic surgery. 114(2) |
ISSN: | 1552-6259 |
Popis: | Surgical risk stratified outcomes after contemporary revascularization strategies have not been well described. We report these outcomes in patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for multivessel coronary disease.A total of 5836 patients with multivessel disease who underwent CABG (n = 4420) or PCI (n = 1416) were included in this retrospective observational analysis. Data were stratified based on The Society of Thoracic Surgeons risk score. A score less than 4% was considered low risk and a score greater than or equal to 4% was considered intermediate-high risk. Outcomes included mortality, inpatient readmissions, and repeat revascularizations.In the CABG population, 3863 (87.3%) were low risk and 557 (12.6%) were intermediate-high risk. The 5-year mortality for the low-risk cohort was 10.9% (95% confidence interval [CI], 9.83%-12.05%), and for the intermediate-high-risk cohort it was 40.1% (95% CI, 35.76%-44.54%). Among those undergoing PCI, 1163 (82.1%) were low risk, while 249 (17.6%) were intermediate-high risk. The 5-year mortality for the low-risk cohort was 21.6% (95% CI, 19.10%-24.26%), and for the intermediate-high-risk cohort it was 61.8% (95% CI, 54.72%-68.70%).This study reports outcomes stratified by surgical risk after PCI or CABG in patients with multivessel coronary disease. These data can help guide the revascularization strategy choice for individual patients. |
Databáze: | OpenAIRE |
Externí odkaz: |